에 대한 최신 뉴스 Celestica (NYSE:CLS) 주식

Celestica

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

Delta Airlines

Large Cap

News

Movers

Trading Ideas

CTTAF

FTAI

ITCI

NVDA

RPRX

SNAP

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 월그린스 부츠 얼라이언스(NASDAQ:WBA)의 주가가 회사가 예상보다 나은 1분기 재무결과를 발표한 후 27.97% 상승했다.

월그린스, 마이크론 및 델타 항공은 지난주 최고 성과를 보여준 10개 대형주 중 일부 (1월 6일-10일)

Mid Cap

$BTC

IBRX

IONQ

IRTC

WULF

이들 10개 중형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 이뮤니티바이오(NASDAQ:IBRX)의 주식은 회사가 재발성 B-세포 비호지킨 림프종에 대한 CAR-NK 세포 치료제의 1상 임상 연구에서 첫 환자에게 투여했다고 발표한 후 49.86% 상승했다.

트럼프 미디어와 스트라이드는 지난주 최고 성과를 보여준 10개 중형주 중 일부 (10월 21일-10월 25일)

Celestica Inc

Exchange Listed Funds Trust Cabana Target Leading Sector Aggressive ETF

Exchange Listed Funds Trust Cabana Target Leading Sector Conservative ETF

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical Inc

Trust for Professional Managers Convergence Long/Short Equity ETF

CLS HOLDINGS USA INC by CLS Holdings USA, Inc.

CLS Holdings USA Inc

Cleanspark Inc

Cabana Target Leading Sector Moderate ETF

CANADIAN LIFE COS SPLT by CANADIAN LIFE COS SPLIT CORP.

Canadian Life Companies Split Corp

Catalyst Bancorp Inc

CHINA OIL & GAS GROUP LTD by China Oil & Gas Group, Ltd.

China Oil And Gas Group Ltd

Argus Research analyst Kevin Heal maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Buy and lowers the price target from $150 to $120.

Price Target

Analyst Ratings

Argus Research Maintains Buy on Celestica, Lowers Price Target to $120

Celestica Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) reported better-than-expected first-quarter earnings after the <a href="https://www.benzinga.com/quote/CLS/earnings">closing bell on Thursday</a>.
The company posted revenue of $2.65 billion, versus estimates of $2.61 billion. Adjusted earnings came in at $1.20 per share, versus estimates of $1.15 per share.
"Celestica delivered a strong first quarter in 2025, achieving revenue of $2.65 billion and non-GAAP adjusted EPS of $1.20, both surpassing the high end of our guidance ranges. This strong performance was further highlighted by our highest ever adjusted operating margin of 7.1%," said Rob Mionis, president and CEO of Celestica.
Celestica guided for second-quarter revenue of $2.58 billion to $2.73 billion versus estimates of $2.77 billion. The company expects second-quarter adjusted earnings to be in the range of $1.17 to $1.27 per share versus Benzinga Pro estimates of $1.24 per share.
The company also raised its full-year 2025 outlook. Celestica raised its full-year revenue guidance from $10.7 billion to $10.85 billion, and raised its earnings outlook from $4.75 per share to $5 per share. The guidance is still below analyst estimates of $12.54 billion in revenue and earnings of $5.76 per share.
Celestica shares fell 3.3% to trade at $86.13 on Monday.
These analysts made changes to their price targets on Celestica following earnings announcement.
<ul>
<li>Barclays analyst George Wang maintained Celestica with an Overweight rating and lowered the price target from $157 to $126.</li>
<li>JP Morgan analyst Samik Chatterjee maintained Celestica with an Overweight rating and raised the price target from $105 to $115.</li>
<li>RBC Capital analyst Paul Treiber, meanwhile, reiterated the stock with an Outperform rating and maintained a $120 price target.</li>
</ul>
Considering buying CLS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="599" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28130258/image-201-1024x599.png" alt="" class="wp-image-891439" style="width:631px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28130258/image-201-1024x599.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28130258/image-201-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28130258/image-201-768x449.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28130258/image-201.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/45038052/top-2-industrials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

These Analysts Revise Their Forecasts On Celestica After Q1 Earnings

<figure class="wp-block-image aligncenter size-large"><img loading="lazy" decoding="async" width="1024" height="582" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071043/Roller-Coaster-1024x582.jpg" alt="" class="wp-image-11680" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071043/Roller-Coaster-1024x582.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071043/Roller-Coaster-300x171.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071043/Roller-Coaster-768x436.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071043/Roller-Coaster.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">We&#8217;re In A Bear Market, And Stocks Have Further To Fall</h2>
That&#8217;s been our basic thesis since early this month. Big market participants (such as Bill Ackman) thought Trump&#8217;s tariffs were a negotiating tack or a bluff. Ergo, the extent of them wasn&#8217;t priced in, and when it was, we would go lower.&nbsp;
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/p/the-64-trillion-question"><img loading="lazy" decoding="async" width="922" height="861" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071148/64-Trillion.jpg" alt="" class="wp-image-11681" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071148/64-Trillion.jpg 922w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071148/64-Trillion-300x280.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071148/64-Trillion-768x717.jpg 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
Whether it makes sense to balance trade is a separate question. We think it does, as does Warren Buffett and as did the late Intel CEO, Andy Grove. But even if it&#8217;s a good policy, there is going to be a period of painful adjustment.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The warnings from public trucking companies, including LTL providers, tells us that the Trade War is about to take a massive toll on the economy. Most Americans are blissfully ignorant that Main Street activity has sharply down shifted.
&mdash; Craig Fuller &#x1f6e9;&#x1f69b;&#x1f682;&#x2693;&#xFE0F; (@FreightAlley) <a href="https://twitter.com/FreightAlley/status/1915970424648708338?ref_src=twsrc%5Etfw">April 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h2 class="wp-block-heading">Trading That Thesis&nbsp;</h2>
It&#8217;s a bearish thesis, so we&#8217;ve mainly focused on adding short exposure, with some exceptions. If something looks cheap&#8211;and likely to appreciate, we go long. And we do so on a day when the market is down. We did just that last Monday, placing long term, bullish bets on two Bitcoin-related names. 
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/p/trade-alert-bitcoin-bull"><img loading="lazy" decoding="async" width="920" height="842" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071408/Bitcoin-Bull.jpg" alt="" class="wp-image-11682" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071408/Bitcoin-Bull.jpg 920w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071408/Bitcoin-Bull-300x275.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071408/Bitcoin-Bull-768x703.jpg 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
We explained our logic there:&nbsp;
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow"><h2 class="wp-block-heading">Why Bitcoin?</h2>
Because Bitcoin is starting to behave like its own asset class, instead of like a more volatile version of the Nasdaq. While the NASDAQ 100-tracking Invesco QQQ Trust (QQQ) is down about 3% as I type this, Bitcoin is up about 2.5%.
<h2 class="wp-block-heading">Why These Two Stocks?</h2>
Because they are both profitable and cheap, with most of their market caps backed by cash and crypto:
<h3 class="wp-block-heading">Company A</h3>
<ul>
<li>Bitcoin Holdings: 742.1 BTC, valued at approximately $69.3 million</li>
<li>Ethereum Holdings: 27,623.9 ETH, valued at approximately $92.1 million</li>
<li>Cash and Cash Equivalents: Approximately $98.6 million</li>
<li>Total Market Capitalization: Approximately $325 million</li>
</ul>
Asset Composition Relative to Market Cap:
<ul>
<li>Bitcoin and Ethereum: ~50%</li>
<li>Cash: ~30%</li>
<li>Combined Liquidity (BTC + ETH + Cash): ~80%</li>
</ul>
<hr class="wp-block-separator has-alpha-channel-opacity" />
<h3 class="wp-block-heading">Company B</h3>
<ul>
<li>Bitcoin Holdings: 2,298 BTC, valued at approximately $214.6 million</li>
<li>Cash and Cash Equivalents: Approximately $8.9 million</li>
<li>Total Market Capitalization: Approximately $295 million</li>
</ul>
Asset Composition Relative to Market Cap:
<ul>
<li>Bitcoin: ~73%</li>
<li>Cash: ~3%</li>
<li>Combined (BTC + Cash): ~76%</li>
</ul>
</blockquote>
Company B was Semler Scientific, Inc. (SMLR), and it finished the week up more than 15%. 
<h2 class="wp-block-heading">Mostly Bearish Bets The Rest Of The Week</h2>
The rest of the week, we mainly added short exposure on market rallies. Specifically, we placed bets against:&nbsp;
<ul>
<li>High yield bonds, via the iShares iBoxx $ High Yield Corporate Bond ETF (HYG)</li>
<li>Trucking companies serving our ports.&nbsp;</li>
<li>Freight forwarders serving American small businesses importing from China.&nbsp;</li>
<li>Other vendors serving those small business.&nbsp;</li>
</ul>
We wrapped up the week with another bet against&nbsp;Nvidia Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) as it bounced above $110.&nbsp;
<figure class="wp-block-image size-full"><a href="https://portfolioarmor.substack.com/p/trade-alert-fading-the-rally-again"><img loading="lazy" decoding="async" width="922" height="815" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071815/Nvidia-Again.jpg" alt="" class="wp-image-11683" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071815/Nvidia-Again.jpg 922w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071815/Nvidia-Again-300x265.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071815/Nvidia-Again-768x679.jpg 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h2 class="wp-block-heading">Balancing Fear And Greed&nbsp;</h2>
We ended the week with three profitable exits, two on bearish trades (including an earlier bet against Nvidia), and one on a bullish put spread on&nbsp;Celestica, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>).&nbsp;
Options
<ol>
<li>Puts on Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>). Bought for $1.81 on 4//14/2025; sold for $2.71 on 4/21/2025. Profit: 50%.</li>
<li>Put spread on Celestica (CLS 0.61%↑). Entered at a net credit of $3.12 on 3/27/2025; exited at a net debit of $2 on 4/25/2025. Profit: 59.6%.</li>
<li>Puts on Nvidia (NVDA -2.83%↓). Bought for $1.56 on 4/9/2025; sold for $4.02 on 4/21/2025. Profit: 158%.</li>
</ol>
Although we were bearish on Monday, we nevertheless decided to take profits on Apple and Nvidia again, as those options were expiring on Friday. In that case, our fear outweighed our greed, and enabled us to have three profitable exits this week instead of just one. We post our trade exits at the end of each week, including our losses. This week, we didn&#8217;t have any exits for losses, which was a welcome change from the previous week.&nbsp;
If you would like to trade alongside us next time, you can subscribe to our trading Substack/occasional email list below.&nbsp;
And if you just want to add some downside protection here,&nbsp;you can download the Portfolio Armor optimal hedging app by aiming your iPhone camera at the QR code below (or by&nbsp;<a href="https://apps.apple.com/us/app/portfolio-armor/id394951144">tapping here</a>, if you&#8217;re reading this on your phone). Our app can help you find the least expensive hedges given your risk tolerance and time frame.
<figure class="wp-block-image size-full"><a href="158%. Although we were bearish on Monday, we nevertheless decided to take profits on Apple and Nvidia again, as those options were expiring on Friday. In that case, our fear outweighed our greed, and enabled us to have three profitable exits this week instead of just one. We post our trade exits at the end of each week, including our losses. This week, we didn't have any exits for losses, which was a welcome change from the previous week. If you would like to trade alongside us next time, you can subscribe to our trading Substack/occasional email list below. And if you just want to add some downside protection here, you can download the Portfolio Armor optimal hedging app by aiming your iPhone camera at the QR code below (or by tapping here, if you're reading this on your phone). Our app can help you find the least expensive hedges given your risk tolerance and time frame."><img loading="lazy" decoding="async" width="200" height="197" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26071945/QR-Code-3-3.jpg" alt="" class="wp-image-11684" /></a></figure>
If you&#8217;d like to stay in touch
You can scan for optimal hedges for individual securities, find our current top ten names, and&nbsp;create hedged portfolios&nbsp;on&nbsp;<a href="https://portfolioarmor.com/">our website</a>.&nbsp;You can also follow Portfolio Armor on X&nbsp;<a href="https://twitter.com/portfolioarmor">here</a>, or become a free subscriber to our trading Substack using the link below (we&#8217;re using that for our occasional emails now).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/"><img loading="lazy" decoding="async" width="581" height="372" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26072116/Widget-6.jpg" alt="" class="wp-image-11685" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26072116/Widget-6.jpg 581w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/26072116/Widget-6-300x192.jpg 300w" sizes="(max-width: 581px) 100vw, 581px" /></a></figure>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Options

Opinion

AAPL

Navigating A Roller Coaster Market

RBC Capital analyst Paul Treiber reiterates Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Outperform and maintains $120 price target.

Reiteration

RBC Capital Reiterates Outperform on Celestica, Maintains $120 Price Target

JP Morgan analyst Samik Chatterjee maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Overweight and raises the price target from $105 to $115.

JP Morgan Maintains Overweight on Celestica, Raises Price Target to $115

Barclays analyst George Wang maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Overweight and lowers the price target from $157 to $126.

Barclays Maintains Overweight on Celestica, Lowers Price Target to $126

Benzinga examined the prospects for <a href="http://www.benzinga.com/trading-ideas" target="_blank" rel="noreferrer noopener">many investors' favorite stocks</a> over the last week — here's a look at some of our top stories.
U.S. markets rebounded this week as President Donald Trump softened his stance on trade and monetary policy. He indicated that tariffs on Chinese imports could decrease from the current 145% and affirmed his support for Federal Reserve Chair Jerome Powell, alleviating investor concerns about central bank independence.
The S&amp;P 500 regained nearly 80% of its post-April 2 losses, with notable gains in technology stocks. ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) led with a 20% weekly increase, while Tesla (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NYSE">TSLA</a>) surged 9.9% after CEO Elon Musk announced a reduced focus on the Department of Government Efficiency (DOGE).
Despite the rally, economic indicators signaled caution. U.S. private sector growth slowed to a 16-month low, and consumer sentiment declined sharply. Inflation expectations rose, with one-year forecasts reaching 6.5%, the highest since 1981, suggesting persistent economic uncertainty.
Benzinga provides daily reports on the stocks most popular with investors. Here are a few of this past week's most bullish and bearish posts that are worth another look.
The Bulls
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44935008/netflix-stock-nears-all-time-high-whats-going-on">"Netflix stock nears all-time high: What's going on?"</a>, by Adam Eckert, reports that Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) shares approached record highs following strong Q1 earnings—$10.54 billion in revenue and $6.61 EPS—driven by robust subscription and advertising growth, with analysts raising price targets up to $1,514 and highlighting the company's insulation from global tariffs due to its digital-only business model.
<a href="https://www.benzinga.com/general/biotech/25/04/44963467/why-is-summit-therapeutics-stock-soaring-on-wednesday">"Why Is Summit Therapeutics Stock Soaring On Wednesday?"</a>, by Vandana Singh, reports that Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) shares surged after partner Akeso, Inc. announced that their Phase 3 HARMONi-6 trial met its primary endpoint, with ivonescimab plus chemotherapy showing a statistically significant improvement in progression-free survival over BeiGene Ltd.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) tislelizumab combo in patients with advanced squamous non-small cell lung cancer.
<a href="https://www.benzinga.com/general/biotech/25/04/44966369/novavaxs-covid-19-vaccine-nears-fda-full-approval-stock-jumps">"Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps"</a>, by Vandana Singh, reports that Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares rose after the company stated its Biologics License Application is approvable and awaits FDA response following a post-marketing data request.
For additional bullish calls of the past week, check out the following:
<a href="https://www.benzinga.com/news/earnings/25/04/44998075/celestica-beats-q1-estimates-raises-fy-outlook-on-strengthening-demand-shares-slide">Celestica Beats Q1 Estimates, Raises FY Outlook On ‘Strengthening Demand,' Shares Slide</a>
<a href="https://www.benzinga.com/25/04/44927300/this-nvidia-backed-ai-upstart-boasts-extremely-rapid-revenue-growth-analyst-initiates-overweight">Nvidia-Backed AI Startup Boasts ‘Extremely Rapid Revenue Growth' &#8211; JPMorgan Initiates With Overweight</a>
<a href="https://www.benzinga.com/trading-ideas/movers/25/04/44995270/why-is-rocket-lab-stock-trading-higher-on-thursday">Why Is Rocket Lab Stock Trading Higher On Thursday?</a>
The Bears
<a href="https://www.benzinga.com/news/earnings/25/04/44996628/intel-q1-earnings-revenue-beat-eps-beat-shares-tumble-on-weak-guidance-chipmaker-plans-swift-actions-to-drive-efficiency">"Intel Q1 earnings: Revenue beat, EPS beat, shares tumble on weak guidance, chipmaker plans ‘swift actions' to drive efficiency"</a>, by Adam Eckert, reports that Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares fell after the company reported first-quarter revenue of $12.67 billion and adjusted earnings of 13 cents per share, both surpassing analyst expectations, but issued a disappointing second-quarter revenue forecast of $11.2–$12.4 billion, prompting CEO Lip-Bu Tan to announce organizational streamlining and cost-cutting measures to enhance efficiency.
<a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">"Amazon stock downgraded, price target slashed as tariffs create uncertainty"</a>, by Erica Kollmann, reports that Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) shares fell after Raymond James analyst Josh Beck downgraded the stock from Strong Buy to Outperform and cut the price target from $275 to $195, citing underestimated EBIT pressures from tariffs and macroeconomic headwinds.
<a href="https://www.benzinga.com/news/earnings/25/04/44966124/ibm-shares-slide-despite-better-than-expected-q1-details">"IBM Shares Slide Despite Better-Than-Expected Q1: Details"</a>, by Erica Kollmann, reports that International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) shares fell despite beating Q1 expectations with $1.60 EPS and $14.54 billion in revenue, as investors reacted to CEO Arvind Krishna's warning that economic uncertainty may cause clients to pause spending.
For more bearish takes, be sure to see these posts:
<a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44962797/enphase-energy-stock-is-tumbling-wednesday-why-investors-are-selling-shares">Enphase Energy Stock Is Tumbling Wednesday: Why Investors Are Selling Shares</a>
<a href="https://www.benzinga.com/analyst-ratings/reiteration/25/04/44965222/metas-fundamentals-look-fragile-heading-into-q1-report-analyst-warns">Meta's Fundamentals Look Fragile Heading Into Q1 Report, Analyst Warns</a>
<a href="https://www.benzinga.com/news/earnings/25/04/44995935/t-mobile-shares-drop-despite-better-than-expected-q1-report-details">T-Mobile Shares Drop Despite Better-Than-Expected Q1 Report: Details</a>
Keep up with all the latest breaking news and trading ideas by following <a href="https://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener">Benzinga</a><a href="http://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener"> on X</a>.
Image created using artificial intelligence via Midjourney.

AMZN

ENPH

INTC

NFLX

NVAX

RKLB

SMMT

TMUS

TSLA

Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back

WIIM

CLS stock has given up its prior loss. Celestica shares were trading lower after the company issued Q2 sales guidance below estimates.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Friday.
Shares of Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) fell sharply in today's pre-market trading following a <a href="https://in.benzinga.com/news/earnings/25/04/44996051/skechers-stock-falls-on-q1-revenue-miss-details">first-quarter revenue miss</a>.
Skechers reported quarterly earnings of $1.34 per share, which beat the analyst consensus estimate of $1.17. Quarterly revenue came in at $2.41 billion, which missed the consensus estimate of $2.43 billion.
Skechers shares dipped 7.2% to $46.82 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>TMC the metals company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) dipped 7.3% to $3.42 in pre-market trading.</li>
<li>Azul S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) fell 7.1% to $1.05 in pre-market trading.</li>
<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) declined 5.9% to $86.70 in pre-market trading after the company issued second-quarter sales guidance below estimates.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) fell 5.7% to $20.27 in pre-market trading. Intel reported upbeat first-quarter financial results, but issued weak outlook for the second quarter. Intel said it expects second-quarter revenue to be in the range of $11.2 billion to $12.4 billion versus estimates of $12.84 billion. The company anticipates a second-quarter earnings loss of 32 cents per share versus estimates for a loss of 16 cents per share.</li>
<li>T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) declined 5.5% to $247.83 in pre-market trading following first-quarter results.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) dipped 4.7% to $11.95 in pre-market trading.</li>
<li>Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) fell 3.8% to $102.14 in today's pre-market trading after the company posted mixed first-quarter results. Gilead Sciences also lowered its fiscal 2025 earnings guidance from a range of $5.95 to $6.35 per share to a range of $5.65 to $6.05 per share, versus the $6.21 estimate.</li>
<li>Fluor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) slipped 3.8% to $34.24 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45001899/alphabet-intel-and-3-stocks-to-watch-heading-into-friday">Alphabet, Intel And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

AZUL

GILD

Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Celestica shares are trading lower after the company issued Q2 sales guidance below estimates.

Celestica Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) reported first-quarter financial results Thursday after the bell. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/04/g44995314/celestica-announces-first-quarter-2025-financial-results">from the quarter</a>.
<ul>
<li>Q1 Revenue: $2.65 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $2.61 billion</li>
</ul>
<ul>
<li>Q1 Adjusted EPS: $1.20, versus estimates of $1.15</li>
</ul>
&#8220;Celestica delivered a strong&nbsp;first quarter&nbsp;in 2025, achieving revenue of&nbsp;$2.65 billion&nbsp;and non-GAAP adjusted EPS of&nbsp;$1.20, both surpassing the high end of our&nbsp;guidance&nbsp;ranges. This strong performance was further highlighted by our highest ever adjusted operating margin of&nbsp;7.1%,&#8221; said Rob Mionis, president and CEO of Celestica.
&#8220;With these results, and a strengthening demand&nbsp;outlook&nbsp;from our CCS customers, we are raising our full-year 2025&nbsp;outlook.&#8221;
See Also: <a href="https://www.benzinga.com/25/04/44995955/alphabet-q1-earnings-highlights-google-search-youtube-cloud-show-robust-momentum">Alphabet Q1 Earnings Highlights: Google Search, YouTube, Cloud Show &#8216;Robust Momentum&#8217;</a>
Outlook: Celestica guided for second-quarter revenue of $2.58 billion to $2.73 billion versus estimates of $2.77 billion. The company expects second-quarter adjusted earnings to be in the range of $1.17 to $1.27 per share versus <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates of $1.24 per share. 
The company also raised its full-year 2025 outlook. Celestica raised its full-year revenue guidance from $10.7 billion to $10.85 billion, and raised its earnings outlook from $4.75 per share to $5 per share. The guidance is still below analyst estimates of $12.54 billion in revenue and earnings of $5.76 per share. 
The company noted that its guidance assumes no material changes to tariffs compared to what&#8217;s currently in effect, and no material changes from current macroeconomic trends and uncertainties. 
Celestica executives will further discuss the quarter on a call with investors and analysts Friday morning at 8 a.m. ET.
CLS Price Action: <a href="http://benzinga.com/quote/cls">Celstica shares</a> were down 3.25% after-hours, trading at $89.15 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: •<a href="https://www.benzinga.com/news/earnings/25/04/44997163/boston-beer-reports-strong-eps-beat-shipment-growth-in-q1"> Boston Beer Reports Strong EPS Beat, Shipment Growth In Q1</a>
Photo: Shutterstock.

Guidance

After-Hours Center

Celestica Beats Q1 Estimates, Raises FY Outlook On 'Strengthening Demand,' Shares Slide

Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) is looking for Q2 Adj EPS of $1.17-$1.27 vs $1.24 analyst estimate. sees sales of $2.575 billion-$2.725 billion vs $2.77 billion analyst estimate.

Celestica Sees Q2 Adj EPS $1.17-$1.27 vs $1.24 Est; Sees Sales $2.575B-$2.725B vs $2.77B Est

Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) raises FY2025 Adj EPS guidance from $4.75 to $5.00 vs $5.76 analyst estimate. Raises FY2025 sales outlook from $10.70 billion to $10.85 billion vs $12.54 billion estimate.

Celestica Raises FY2025 Adj EPS Guidance from $4.75 to $5.00 vs $5.76 Est; Raises FY2025 Sales Guidance from $10.70B to $10.85B vs $12.54B Est

Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) reported quarterly earnings of $1.20 per share which beat the analyst consensus estimate of $1.15 by 4.35 percent. This is a 39.53 percent increase over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $2.65 billion which beat the analyst consensus estimate of $2.61 billion by 1.68 percent. This is a 19.92 percent increase over sales of $2.21 billion the same period last year.

Earnings Beats

Celestica Q1 Adj. EPS $1.20 Beats $1.15 Estimate, Sales $2.65B Beat $2.61B Estimate

ADXN

ALEX

ALLE

AMAL

AMBP

APOG

APPF

BAFN

BCPC

BELFA

BELFB

BFST

BHLB

BWMX

CBRE

CIVB

CMCSA

CNOB

COUR

CUBI

CURB

DAIO

DGICA

DGICB

ERIE

FARO

FBIZ

FCFS

FCNCA

FFBC

FRME

GBCI

GLPI

GNFT

GOOG

GOOGL

HELE

HFWA

IBCP

INDV

ITGR

KNSL

KRNY

LADR

LYTS

MBLY

MGRC

MMSI

MOFG

Earnings Scheduled For April 24, 2025

AAOI

ACMR

AEVA

ALAB

ALGM

ANET

AOSL

CAMT

CEVA

CIEN

COHR

COMM

CRDO

CRSR

DELL

DOCN

ENTG

FLEX

FORM

GDDY

GLOB

ICHR

LDTC

LITE

LOGI

LRCX

LSCC

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MKSI

MOVE

MTSI

NTAP

NVMI

NXPI

OKTA

ONTO

PRSO

PSTG

RGTI

RMBS

SELX

SHOP

SITM

SMTC

SNOW

SYNA

TSSI

TWLO

UCTT

VNET

ZBRA

Shares of companies within the broader technology sector are trading higher amid overall market strength after President Trump said he had no intention of firing Fed Chair Powell. Additionally, Trump indicated the final tariff rate would be less than the current 145% but not 0%.

Celestica shares are trading higher. JP Morgan maintained an Overweight rating on the stock.

JP Morgan maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Overweight and lowers the price target from $166 to $105.

JP Morgan Maintains Overweight on Celestica, Lowers Price Target to $105

Comments

Celestica

뉴스

에 대한 최신 뉴스 Celestica (NYSE:CLS) 주식

일요일, 1월 12, 2025

월요일, 10월 28, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌